Mission: Affordable—GSK, Bharat Biotech Slash Malaria Shot Costs

Unknown Apr 02, 2026 1,250 Views

As a significant stimulus for global health equity, Bharat Biotech and GlaxoSmithKline (GSK) have announced that they intend to reduce the price of the world's first malaria vaccine, RTS,S/AS01E, by more than half by 2028. This is as part of a long-term approach to promote sustainable and aff...